Clinical implications of aspirin resistance (Q28221576)

Expert Review of Cardiovascular Therapy

Europe PubMed Central

title

Clinical implications of aspirin resistance (English)

0 references

1 reference

Darshana Patel

1

0 references

Majaz Moonis

series ordinal

2

0 references

language of work or name

English

0 references

publication date

September 2007

0 references

published in

0 references

volume

5

0 references

issue

5

0 references

page(s)

969-75

0 references

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.5.969

A review of aspirin resistance; definition, possible mechanisms, detection with platelet function tests, and its clinical outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.5.969

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.5.969

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.5.969

Aspirin resistance: is it real? Is it clinically significant?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.5.969

Relation between atherosclerosis risk factors and aspirin resistance in a primary prevention population

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.5.969

Measuring antiplatelet drug effects in the laboratory

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.5.969

Platelet function testing in cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.5.969

Aspirin resistance: definition, mechanisms and clinical read-outs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.5.969

Cyclooxygenase-2 in human platelets as a possible factor in aspirin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.5.969

Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.5.969

Monitoring acetylsalicylic acid effects with the platelet function analyzer PFA-100

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.5.969

Assessing aspirin responsiveness in subjects with multiple risk factors for vascular disease with a rapid platelet function analyzer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.5.969

Effect of a single dose aspirin on platelets in humans with multiple risk factors for coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.5.969

A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.5.969

Aspirin non-responder status in patients with recurrent cerebral ischemic attacks

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.5.969

Adherence to a prophylactic medication regimen in patients with symptomatic versus asymptomatic ischemic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.5.969

Compliance as a critical consideration in patients who appear to be resistant to aspirin after healing of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.5.969

Effect of aspirin treatment in patients with peripheral arterial disease monitored with the platelet function analyzer PFA-100

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.5.969

Pathophysiological impact of transcellular metabolism for the induction of clinical aspirin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.5.969

Enhanced antiplatelet effect of clopidogrel in patients whose platelets are least inhibited by aspirin: a randomized crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.5.969

Genetic and environmental contributions to platelet aggregation: the Framingham heart study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.5.969

Pharmacogenomics--drug disposition, drug targets, and side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.5.969